Core summary of product characteristics for human plasma derived antithrombin - Scientific guideline

HumanProduct informationScientific guidelines

On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.

This document describes the information to be included in the summary of product characteristics for human plasma derived antithrombin.

Keywords: Congenital antithombin deficiency, acquired antithombin deficiency, summary of product characteristics (SPC)

Current effective version

Guideline on the Core SPC for human plasma derived antithrombin

Adopted Reference Number: CPMP/BPWG/3226/99 Legal effective date: 01/07/2002

English (EN) (167.26 KB - PDF)

First published: 17/01/2002 Last updated: 17/01/2002